Hints and tips:
Related Special Reports
...While Anderson has warned the revamp will lead to “significant” job cuts, Bayer employees have been supportive....
...Much of Bayer’s debt is long-term but about €4.3bn of bonds mature this year. For now, Anderson is trying to fix Bayer organically....
...But even optimists would struggle with no direction at all on Bayer’s future structure....
...“The public debate about Bayer’s future was too narrowly focused on a break-up,” he said, adding that Anderson was right to address Bayer’s underlying problems....
...The Texas native, who joined Bayer last summer after his predecessor Werner Baumann was pushed out, argued that Bayer first needed to focus on fixing its financial and operating problems, warning that the...
...US trial attorneys are eager to keep fighting Bayer in court....
...to Bayer....
...Bayer paid a dividend of €2.40 for 2022. Analysts had expected Bayer to pay a dividend of €1.92 per share for 2023, a far more modest cut....
...Bayer closed down nearly 8 per cent, putting its market cap below €26bn....
...“Bayer is running out of options strategically as well as financially.”...
...that Roundup causes cancer, which Bayer denies....
...Mentioned in this podcast: Buffett sounds wildfire alarm as utilities industry enters new era Bayer slashes dividend by 95% as it steps up effort to cut debt Bayer’s struggling Roundup court strategy...
...Bayer will give a detailed outlook for next year in March....
...These patent expiries, declining farm incomes and a battery of legal claims — estimated at €9bn by Berenberg’s Sebastian Bray — weigh on Bayer shares....
...Bayer last week abandoned a trial of blood-thinner asundexian after it did not work as hoped to treat heart disease....
...In Bayer’s case, its CropScience division, which provides seeds and weedkillers to farmers, feared in 2016 that it could be marginalised as a massive consolidation wave swept through the sector....
...Bayer paid $65bn for Monsanto assets that included a glyphosate weedkiller called Roundup....
...Bayer: Shares in the German chemicals and pharma company gained 2 per cent after reports it may spin off its CropScience unit....
...Bayer has set aside $6.4bn for future Roundup litigation costs, and S&P has estimated that Bayer will spend $3bn on litigation overall this year....
...For years, companies such as McKinsey, Air France and Bayer have been buying carbon credits from Southern Cardamom, one of Cambodia’s largest nature restoration projects....
...Anderson joined Bayer in April and formally became CEO this month....
...The region-wide Stoxx 600 gained 0.1 per cent, while Germany’s Dax dipped 0.1 per cent, as shares in Frankfurt-listed Bayer AG plunged 18 per cent after the group abandoned a key late-stage trial of a blood-thinning...
...In a presentation sent to Bayer earlier this week, the small activist investor, which says it holds an undisclosed stake, welcomed Bayer’s appointment of Bill Anderson, former head of Roche’s pharmaceutical...
...One of his main goals will be to slim down Bayer’s internal bureaucracy....
...Bayer’s shares have fallen nearly 60 per cent since 2015....
International Edition